Skip to main content
Livermore
Livermore
ZHEN

Fifth Third Bancorp

SEC CIK
0000035527
Latest filing
Aug 5, 2026

ARWR holding history

Arrowhead Pharmaceuticals, Inc. in every 13F filed by Fifth Third Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ARWR overviewAll 13F holders of ARWRFull Q2 2026 holdings

Shares (Q2 2026)
30,534
Value
$2.49M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of ARWR by Fifth Third Bancorp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202630,534$2.49M<0.1%−2,913−8.7%ReducedHolders
Q1 202633,447$2.10M<0.1%+32,230+2,648.3%AddedHolders
Q4 20251,217$80.8K<0.1%+67+5.8%AddedHolders
Q3 20251,150$39.7K<0.1%−215−15.8%ReducedHolders
Q2 20251,365$21.6K<0.1%+894+189.8%AddedHolders
Q1 2025471$6.00K<0.1%−899−65.6%ReducedHolders
Q4 20241,370$25.8K<0.1%+53+4.0%AddedHolders
Q3 20241,317$25.5K<0.1%+131+11.0%AddedHolders
Q2 20241,186$30.8K<0.1%+354+42.5%AddedHolders
Q1 2024832$23.8K<0.1%−330−28.4%ReducedHolders
Q4 20231,162$35.6K<0.1%+174+17.6%AddedHolders
Q3 2023988$26.5K<0.1%+522+112.0%AddedHolders
Q2 2023466$16.6K<0.1%+326+232.9%AddedHolders
Q1 2023140$3.56K<0.1%−203−59.2%ReducedHolders
Q4 2022343$13.9K<0.1%−75−17.9%ReducedHolders
Q3 2022418$14.0K<0.1%−135−24.4%ReducedHolders
Q2 2022553$19.0K<0.1%+338+157.2%AddedHolders
Q1 2022215$10.0K<0.1%−222−50.8%ReducedHolders
Q4 2021437$29.0K<0.1%+131+42.8%AddedHolders
Q3 2021306$19.0K<0.1%+136+80.0%AddedHolders
Q2 2021170$14.0K<0.1%+40+30.8%AddedHolders
Q1 2021130$9.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.